Profile picture

Doctor Rafael Rascon Sabido

Mexican Institute of Social Security (IMSS), Veracruz (Mexico)
Follow
Biography
Dr. Rafael Rascon its Cardiologist from Veracruz Mexico, have a specialty in Echocardiography, and clinical experience in Acute Care and Cardioncology. Have a Master en Transesophageal echo for UMP Madrid. Spain.
Logo ESC

Contributor content

Safety and effectiveness of the use of ivabradine in patients with HFrEF heart failure and renal replacement therapy with hemodialysis
Presentation
Safety and effectiveness of the use of ivabradine in patients with HFrEF heart failure and renal replacement therapy with hemodialysis
Safety and use de trimetazidine in Cancer Therapy-Related Cardiac Dysfunction (CTRCD) secondary to breast cancer for LVEF recovery.
Presentation
Safety and use de trimetazidine in Cancer Therapy-Related Cardiac Dysfunction (CTRCD) secondary to breast cancer for LVEF recovery.
Safety and effect of EMPAGLIFOZIN in patients with HF reduced LVEF in renal function replacement therapy. Adjustments needed for real life
Presentation
Safety and effect of EMPAGLIFOZIN in patients with HF reduced LVEF in renal function replacement therapy. Adjustments needed for real life
Efficacy of half-dose intermittent levosimendan in day hospital for reduce mortality and hospitalization in patients with heart failure and reduced ejection fraction
Presentation
Efficacy of half-dose intermittent levosimendan in day hospital for reduce mortality and hospitalization in patients with heart failure and reduced ejection fraction
Left bundle branch block correction with conduction system pacing in a heart failure patient
Presentation
Left bundle branch block correction with conduction system pacing in a heart failure patient
Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.
Presentation
Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.
Efficacy and safety of sacubitril-valsartan in heart failure with reduced ejection fraction in end-stage renal patients.
Presentation
Efficacy and safety of sacubitril-valsartan in heart failure with reduced ejection fraction in end-stage renal patients.
Hydrochlorothiazide for the treatment of acute volume overload worsening heart failure
Presentation
Hydrochlorothiazide for the treatment of acute volume overload worsening heart failure
Evaluation of right atrial and ventricular function with 3D echocardiography in acute pulmonary thromboembolism and its 6-month prognosis
Presentation
Evaluation of right atrial and ventricular function with 3D echocardiography in acute pulmonary thromboembolism and its 6-month prognosis
Prevalence and risk factors for ventricular remodeling and pulmonary arterial hypertension in systemic erythematosus lupus
Presentation
Prevalence and risk factors for ventricular remodeling and pulmonary arterial hypertension in systemic erythematosus lupus

ESC 365 is supported by